相似文献
1
Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors.新冠疫情的另一个后果：选择性5-羟色胺再摄取抑制剂的可能新用途
Clin Nurse Spec. 2022;36(5):241-243. doi: 10.1097/NUR.0000000000000696.
2
Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors.2019年冠状病毒病大流行的另一个结果：选择性5-羟色胺再摄取抑制剂的可能重新应用。
Clin Nurse Spec. 2022;36(5):E11. doi: 10.1097/NUR.0000000000000698.
3
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?选择性 5-羟色胺再摄取抑制剂的药物再利用：这些药物能帮助对抗 COVID-19 并拯救生命吗？
J Clin Neurosci. 2021 Jun;88:163-172. doi: 10.1016/j.jocn.2021.03.010. Epub 2021 Mar 19.
4
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer's Disease Prevention.重新利用血清素再摄取抑制剂的机会：在炎症、感染、癌症、神经保护和预防老年痴呆症中的潜在用途。
Pharmacopsychiatry. 2022 Jan;55(1):24-29. doi: 10.1055/a-1686-9620. Epub 2021 Dec 7.
5
New prescription fills of selective serotonin reuptake inhibitors before and during the COVID-19 pandemic in Los Angeles County, California.加利福尼亚州洛杉矶县 COVID-19 大流行前后新型选择性 5-羟色胺再摄取抑制剂处方量。
J Affect Disord. 2022 Dec 15;319:507-510. doi: 10.1016/j.jad.2022.08.119. Epub 2022 Aug 31.
6
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?选择性 5-羟色胺再摄取抑制剂在 COVID-19 期间是否具有神经保护作用？
Eur J Pharmacol. 2020 Dec 15;889:173629. doi: 10.1016/j.ejphar.2020.173629. Epub 2020 Oct 3.
7
Potential of Selective Serotonin Reuptake Inhibitors in Preventing Clinical Deterioration of COVID-19.选择性5-羟色胺再摄取抑制剂在预防新型冠状病毒肺炎临床病情恶化中的潜力
Psychiatr Danub. 2022 Winter;34(4):792-793.
8
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism.
Pharmacopsychiatry. 2022 Nov;55(6):305-306. doi: 10.1055/a-1909-2198. Epub 2022 Aug 18.
9
COVID-19 mortality among selective serotonin reuptake inhibitor users: author's reply.
Clin Microbiol Infect. 2024 Jun;30(6):838-839. doi: 10.1016/j.cmi.2024.02.022. Epub 2024 Feb 29.
10
Re: COVID-19 mortality among selective serotonin reuptake inhibitor users by Stauning et al.
Clin Microbiol Infect. 2024 Jun;30(6):836-837. doi: 10.1016/j.cmi.2024.02.007. Epub 2024 Feb 10.
本文引用的文献
1
Fluvoxamine for the treatment of COVID-19.氟伏沙明用于治疗COVID-19。
Lancet Glob Health. 2022 Mar;10(3):e331. doi: 10.1016/S2214-109X(21)00592-1.
2
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.COVID-19 患者处方选择性 5-羟色胺再摄取抑制剂抗抑郁药的死亡风险。
JAMA Netw Open. 2021 Nov 1;4(11):e2133090. doi: 10.1001/jamanetworkopen.2021.33090.
3
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.氟伏沙明早期治疗对 COVID-19 患者急诊和住院风险的影响：TOGETHER 随机、平台临床试验。
Lancet Glob Health. 2022 Jan;10(1):e42-e51. doi: 10.1016/S2214-109X(21)00448-4. Epub 2021 Oct 28.
4
Biomarkers of Post-COVID Depression.新冠后抑郁症的生物标志物。
J Clin Med. 2021 Sep 14;10(18):4142. doi: 10.3390/jcm10184142.
5
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19.氟伏沙明：作用机制及其在 COVID-19 中作用的综述
Front Pharmacol. 2021 Apr 20;12:652688. doi: 10.3389/fphar.2021.652688. eCollection 2021.
6
Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19.氟伏沙明早期治疗冠状病毒病19的前瞻性队列研究。
Open Forum Infect Dis. 2021 Feb 1;8(2):ofab050. doi: 10.1093/ofid/ofab050. eCollection 2021 Feb.
7
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.抗抑郁药的使用与 COVID-19 住院患者插管或死亡风险降低的关联：一项观察性研究的结果。
Mol Psychiatry. 2021 Sep;26(9):5199-5212. doi: 10.1038/s41380-021-01021-4. Epub 2021 Feb 4.
8
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
9
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.氟伏沙明对比安慰剂在伴有症状的 COVID-19 门诊患者中的临床恶化：一项随机临床试验。
JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.
10
The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.选择性 5-羟色胺再摄取抑制剂在冠状病毒病患者中的可能免疫调节和抗炎作用。
Med Hypotheses. 2020 Nov;144:110140. doi: 10.1016/j.mehy.2020.110140. Epub 2020 Jul 26.
Zotero 插件